These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 17051832
1. Nano- or submicron-sized liposomes as carriers for drug delivery. Fang JY. Chang Gung Med J; 2006; 29(4):358-62. PubMed ID: 17051832 [Abstract] [Full Text] [Related]
2. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Maeda H, Bharate GY, Daruwalla J. Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661 [Abstract] [Full Text] [Related]
3. Can drug-bearing liposomes penetrate intact skin? El Maghraby GM, Williams AC, Barry BW. J Pharm Pharmacol; 2006 Apr; 58(4):415-29. PubMed ID: 16597359 [Abstract] [Full Text] [Related]
4. Drug delivery in cancer using liposomes. Dass CR. Methods Mol Biol; 2008 Apr; 437():177-82. PubMed ID: 18369969 [Abstract] [Full Text] [Related]
6. Liposomes: a drug carrier system for topical treatment in dermatology. Schmid MH, Korting HC. Crit Rev Ther Drug Carrier Syst; 1994 Apr; 11(2-3):97-118. PubMed ID: 7600589 [Abstract] [Full Text] [Related]
7. Vesicular carriers for dermal drug delivery. Sinico C, Fadda AM. Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979 [Abstract] [Full Text] [Related]
8. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas. Hwang TL, Lee WR, Hua SC, Fang JY. J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180 [Abstract] [Full Text] [Related]
9. [Targeting of anti-cancer drugs with nano-sized carrier system]. Yokoyama M, Okano T. Nihon Rinsho; 1998 Dec; 56(12):3227-34. PubMed ID: 9883646 [Abstract] [Full Text] [Related]
10. Liposome-based drug delivery systems. Langner M, Kral TE. Pol J Pharmacol; 1999 Dec; 51(3):211-22. PubMed ID: 10600035 [Abstract] [Full Text] [Related]
12. Physical mechanisms and methods employed in drug delivery to tumors. Besić E. Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107 [Abstract] [Full Text] [Related]
13. [Drug delivery systems using nano-sized drug carriers]. Nakayama M, Okano T. Gan To Kagaku Ryoho; 2005 Jul; 32(7):935-40. PubMed ID: 16044950 [Abstract] [Full Text] [Related]
14. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. McNeeley KM, Karathanasis E, Annapragada AV, Bellamkonda RV. Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688 [Abstract] [Full Text] [Related]
15. Current progress and future prospects of liposomes in dermal drug delivery. Moghimi SM, Patel HM. J Microencapsul; 1993 Aug; 10(2):155-62. PubMed ID: 8331490 [Abstract] [Full Text] [Related]
16. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X, Ding L, Xu Y, Wang Y, Ping Q. Int J Pharm; 2009 May 21; 373(1-2):116-23. PubMed ID: 19429296 [Abstract] [Full Text] [Related]
17. Prodrug strategies in anticancer chemotherapy. Kratz F, Müller IA, Ryppa C, Warnecke A. ChemMedChem; 2008 Jan 21; 3(1):20-53. PubMed ID: 17963208 [Abstract] [Full Text] [Related]
18. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Pharmazie; 2007 Feb 21; 62(2):133-7. PubMed ID: 17341034 [Abstract] [Full Text] [Related]